• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣植入术后预测早期死亡率的多参数风险评分比较

Comparison of multiparametric risk scores for predicting early mortality after transcatheter aortic valve implantation.

作者信息

Carmo João, Teles Rui Campante, Madeira Sérgio, Ferreira António, Brito João, Nolasco Tiago, Gonçalves Pedro de Araújo, Gabriel Henrique Mesquita, Raposo Luís, Vale Nelson, Ribeiras Regina, Abecasis Miguel, Almeida Manuel de Sousa, Neves José Pedro, Mendes Miguel

机构信息

Departamento de Cardiologia, Hospital de Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal.

Departamento de Cardiologia, Hospital de Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal.

出版信息

Rev Port Cardiol (Engl Ed). 2018 Jul;37(7):585-590. doi: 10.1016/j.repc.2017.09.028. Epub 2018 Jun 29.

DOI:10.1016/j.repc.2017.09.028
PMID:30008314
Abstract

INTRODUCTION

Surgical risk scores are widely used to identify patients at high surgical risk who may benefit from transcatheter aortic valve implantation (TAVI). A multiparametric TAVI mortality risk score based on a French registry (FRANCE-2) has recently been developed. The aim of our study was to compare the 30-day mortality prediction performance of the FRANCE-2, EuroSCORE II and STS scores.

METHODS

We retrospectively studied 240 patients from a single-center prospective registry who underwent TAVI between January 2008 and December 2015. All scores were assessed for calibration and discrimination using calibration-in-the-large and ROC curve analysis, respectively.

RESULTS

The observed mortality was 5.8% (n=14). The median EuroSCORE II, STS and FRANCE-2 scores were 5.0 (IQR 3.2-8.3), 5.1 (IQR 3.6-7.1) and 2.0 (IQR 1.0-3.0), respectively. Discriminative power was greater for EuroSCORE II (C-statistic 0.67) and STS (C-statistic 0.67) than for FRANCE-2 (C-statistic 0.53), but this was not statistically significant (p=0.26). All scores showed adequate calibration.

CONCLUSIONS

All scores showed modest performance in early mortality prediction after TAVI. Despite being derived from a TAVI population, FRANCE-2 was no better than surgical risk scores in our population.

摘要

引言

手术风险评分被广泛用于识别手术风险较高的患者,这些患者可能从经导管主动脉瓣植入术(TAVI)中获益。最近基于法国注册研究(FRANCE-2)开发了一种多参数TAVI死亡率风险评分。我们研究的目的是比较FRANCE-2、欧洲心脏手术风险评估系统II(EuroSCORE II)和胸外科医师协会(STS)评分对30天死亡率的预测性能。

方法

我们回顾性研究了2008年1月至2015年12月期间在单中心前瞻性注册研究中接受TAVI的240例患者。分别使用大样本校准和ROC曲线分析评估所有评分的校准和区分能力。

结果

观察到的死亡率为5.8%(n = 14)。EuroSCORE II、STS和FRANCE-2评分的中位数分别为5.0(四分位间距[IQR] 3.2 - 8.3)、5.1(IQR 3.6 - 7.1)和2.0(IQR 1.0 - 3.0)。EuroSCORE II(C统计量0.67)和STS(C统计量0.67)的区分能力大于FRANCE-2(C统计量0.53),但差异无统计学意义(p = 0.26)。所有评分均显示出充分的校准。

结论

所有评分在TAVI术后早期死亡率预测方面表现一般。尽管FRANCE-2源自TAVI人群,但在我们的研究人群中,其并不优于手术风险评分。

相似文献

1
Comparison of multiparametric risk scores for predicting early mortality after transcatheter aortic valve implantation.经导管主动脉瓣植入术后预测早期死亡率的多参数风险评分比较
Rev Port Cardiol (Engl Ed). 2018 Jul;37(7):585-590. doi: 10.1016/j.repc.2017.09.028. Epub 2018 Jun 29.
2
Surgical Risk Scores Applied to Transcatheter Aortic Valve Implantation: Friends or Foes? Short-Term and Long-Term Outcomes From a Single-Center Registry.应用于经导管主动脉瓣植入术的手术风险评分:是友是敌?来自单中心注册研究的短期和长期结果
J Invasive Cardiol. 2019 Oct;31(10):E282-E288.
3
Value of the "TAVI2-SCORe" versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation.“TAVI2评分”与手术风险评分对511例接受经导管主动脉瓣植入术患者1年死亡率预测的价值
Am J Cardiol. 2015 Jan 15;115(2):234-42. doi: 10.1016/j.amjcard.2014.10.029. Epub 2014 Oct 29.
4
External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart Registration.荷兰心脏注册研究中经导管主动脉瓣植入术(TAVI)后30天死亡率现有预测模型的外部验证
Int J Cardiol. 2020 Oct 15;317:25-32. doi: 10.1016/j.ijcard.2020.05.039. Epub 2020 May 22.
5
Prediction of 30-day mortality after transcatheter aortic valve implantation: a comparison of logistic EuroSCORE, STS score, and EuroSCORE II.经导管主动脉瓣植入术后30天死亡率的预测:逻辑欧洲心脏手术风险评估系统、胸外科医师协会评分和欧洲心脏手术风险评估系统II的比较
J Heart Valve Dis. 2014 Sep;23(5):567-74.
6
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI.欧洲心脏手术风险评估系统II(EuroSCORE II)和胸外科医师协会(STS)评分作为经导管主动脉瓣植入术(TAVI)患者死亡率的预测指标
Rev Assoc Med Bras (1992). 2016 Jan-Feb;62(1):32-7. doi: 10.1590/1806-9282.62.01.32.
7
Performance of surgical risk scores to predict mortality after transcatheter aortic valve implantation.手术风险评分预测经导管主动脉瓣植入术后死亡率的效能
Arq Bras Cardiol. 2015 Sep;105(3):241-7. doi: 10.5935/abc.20150084. Epub 2015 Jul 31.
8
Outcome prediction following transcatheter aortic valve implantation: Multiple risk scores comparison.经导管主动脉瓣植入术后的结局预测:多种风险评分比较
Cardiol J. 2016;23(2):169-77. doi: 10.5603/CJ.a2015.0081. Epub 2015 Dec 29.
9
EuroSCORE II and the STS score are more accurate in transapical than in transfemoral transcatheter aortic valve implantation.欧洲心脏手术风险评估系统II(EuroSCORE II)和胸外科医师协会(STS)评分在经心尖经导管主动脉瓣植入术中比在经股动脉经导管主动脉瓣植入术中更准确。
Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):413-419. doi: 10.1093/icvts/ivx343.
10
Performance of contemporary surgical risk scores for transcatheter aortic valve implantation: A meta-analysis.当代经导管主动脉瓣植入手术风险评分的性能:一项荟萃分析。
Int J Cardiol. 2017 Jun 1;236:350-355. doi: 10.1016/j.ijcard.2016.12.188. Epub 2017 Jan 16.

引用本文的文献

1
Futility in Transcatheter Aortic Valve Implantation: A Search for Clarity.经导管主动脉瓣植入术的无效性:寻求明确解释
Interv Cardiol. 2022 Jan 18;17:e01. doi: 10.15420/icr.2021.15. eCollection 2022 Jan.
2
TAVR: A Review of Current Practices and Considerations in Low-Risk Patients.经导管主动脉瓣置换术:低危患者的当前实践和考虑因素综述。
J Interv Cardiol. 2020 Dec 24;2020:2582938. doi: 10.1155/2020/2582938. eCollection 2020.